Understanding the Latest Therapeutic Advances in Multiple Myeloma: Expert Guidance and Implications for Treatment Decisions

Gain expert perspective on the latest advances in treatment of multiple myeloma in this comprehensive educational program. Download the Webcast to learn from the experts in myeloma care, and then download the slides for use in your own presentations.
Shaji Kumar, MD
Sagar Lonial, MD

Downloadable Slides

Download these slides from our live meeting series on myeloma to review the current clinical data on treating your patients with myeloma, from diagnosis through managing relapsed/refractory disease, and then use the slides in your own presentations.

Shaji Kumar, MD Sagar Lonial, MD Released: January 14, 2019
Provided by the Annenberg Center for Health Sciences at Eisenhower

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)

This activity is supported by educational grants from
Celgene Corporation
Takeda Oncology

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?